Matrix-free microfluidic 3D biomimetic chip for identifying type I collagen on doxorubicin treated MDA-MB-231 cell

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Microfluidics and Nanofluidics

• Publication date

  2025-06-30

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s10404-025-02827-2
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Microfluidic platform for studying the anti‐cancer effect of ursolic acid on tumor spheroid

  2022cited by this paper
• Inhibition of lysyl oxidase‐like 2 overcomes adhesion‐dependent drug resistance in the collagen‐enriched liver cancer microenvironment

  2022cited by this paper
• Microfluidic Arrays of Breast Tumor Spheroids for Drug Screening and Personalized Cancer Therapies

  2021cited by this paper
• β1-Integrin binding to collagen type 1 transmits breast cancer cells into chemoresistance by activating ABC efflux transporters.

  2020cited by this paper
• Targeting Discoidin Domain Receptor 1 (DDR1) Signaling and Its Crosstalk with β1-Integrin Emerges as a Key Factor for Breast Cancer Chemosensitization upon Collagen Type 1 Binding

  2020cited by this paper
• Integrins as biomechanical sensors of the microenvironment

  2019cited by this paper
• Spheroid Culture System Methods and Applications for Mesenchymal Stem Cells

  2019cited by this paper
• 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs

  2018cited by this paper
• Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins

  2018cited by this paper
• TGF-β–independent CTGF induction regulates cell adhesion mediated drug resistance by increasing collagen I in HCC

  2017cited by this paper
• Microfluidic-Based Generation of 3D Collagen Spheres to Investigate Multicellular Spheroid Invasion.

  2017cited by this paper
• Differential response to doxorubicin in breast cancer subtypes simulated by a microfluidic tumor model

  2017cited by this paper
• Tumor microenvironment and therapeutic response.

  2017influential reference
• Physical and Chemical Gradients in the Tumor Microenvironment Regulate Tumor Cell Invasion, Migration, and Metastasis.

  2016cited by this paper
• miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1

  2016cited by this paper
• Membranous expressions of Lewis y and CAM-DR-related markers are independent factors of chemotherapy resistance and poor prognosis in epithelial ovarian cancer.

  2015cited by this paper
• Spherical Cancer Models in Tumor Biology1

  2015cited by this paper
• Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing

  2015cited by this paper
• Optimizing long-circulating liposomes for delivery of simvastatin to C26 colon carcinoma cells

  2015cited by this paper
• Drug cytotoxicity and signaling pathway analysis with three-dimensional tumor spheroids in a microwell-based microfluidic chip for drug screening.

  2015cited by this paper
• 3D tumor models: history, advances and future perspectives.

  2014influential reference
• Advances in microfluidic materials, functions, integration, and applications.

  2013cited by this paper
• Microfluidic chip-based technologies: emerging platforms for cancer diagnosis

  2013cited by this paper
• Mechanisms and insights into drug resistance in cancer

  2013cited by this paper
• Collagen/β1 integrin signaling up-regulates the ABCC1/MRP-1 transporter in an ERK/MAPK-dependent manner

  2012cited by this paper
• α2β1 Integrin Promotes Chemoresistance against Doxorubicin in Cancer Cells through Extracellular Signal-regulated Kinase (ERK)*

  2012cited by this paper
• A review of three-dimensional in vitro tissue models for drug discovery and transport studies.

  2011cited by this paper
• Environment-mediated drug resistance: a major contributor to minimal residual disease

  2009cited by this paper
• Recent advances in three‐dimensional multicellular spheroid culture for biomedical research

  2008cited by this paper
• A perfusable 3D cell–matrix tissue culture chamber for in situ evaluation of nanoparticle vehicle penetration and transport

  2008cited by this paper
• Rapid Generation of Single-Tumor Spheroids for High-Throughput Cell Function and Toxicity Analysis

  2006cited by this paper
• Evidence for the isolation, growth, and characterization of malignant cells in primary cultures of human tumors

  2003cited by this paper
• Selection of chemotherapy by ex vivo assessment of tumor sensitivity to cytotoxic drugs

  2002cited by this paper
• A novel model of solute transport in a hollow-fiber bioartificial pancreas based on a finite element method.

  2002cited by this paper
• Integrins and extracellular matrix: a novel mechanism of multidrug resistance

  2002cited by this paper
• The multilayered postconfluent cell culture as a model for drug screening.

  2000cited by this paper
• Integrin and ECM functions: roles in vertebrate development.

  2000cited by this paper
• Review of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity testing for patients with cancer.

  1999cited by this paper
• Multicellular spheroids: a three‐dimensional in vitro culture system to study tumour biology

  1998cited by this paper
• An experimental and mathematical model for the extravascular transport of a DNA intercalator in tumours.

  1997cited by this paper
• Growth and chemotherapeutic response of cells in a hollow-fiber in vitro solid tumor model.

  1994cited by this paper
• A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis.

  1993cited by this paper

• Collagen Type I as a Biological Barrier Interface in Biomimetic Microfluidic Devices: Properties, Applications, and Challenges

  2026cites this paper